Oxygen-permeable microwell device maintains islet mass and integrity during shipping
dc.contributor.author | Rojas-Canales, D. | |
dc.contributor.author | Waibel, M. | |
dc.contributor.author | Forget, A. | |
dc.contributor.author | Penko, D. | |
dc.contributor.author | Nitschke, J. | |
dc.contributor.author | Harding, F. | |
dc.contributor.author | Delalat, B. | |
dc.contributor.author | Blencowe, A. | |
dc.contributor.author | Loudovaris, T. | |
dc.contributor.author | Grey, S. | |
dc.contributor.author | Thomas, H. | |
dc.contributor.author | Kay, T. | |
dc.contributor.author | Drogemuller, C. | |
dc.contributor.author | Voelcker, N. | |
dc.contributor.author | Coates, P. | |
dc.date.issued | 2018 | |
dc.description.abstract | Islet transplantation is currently the only minimally invasive therapy available for patients with type 1 diabetes that can lead to insulin independence; however, it is limited to only a small number of patients. Although clinical procedures have improved in the isolation and culture of islets, a large number of islets are still lost in the pre-transplant period, limiting the success of this treatment. Moreover, current practice includes islets being prepared at specialized centers, which are sometimes remote to the transplant location. Thus, a critical point of intervention to maintain the quality and quantity of isolated islets is during transportation between isolation centers and the transplanting hospitals, during which 20-40% of functional islets can be lost. The current study investigated the use of an oxygen-permeable PDMS microwell device for long-distance transportation of isolated islets. We demonstrate that the microwell device protected islets from aggregation during transport, maintaining viability and average islet size during shipping. | |
dc.description.statementofresponsibility | Darling M Rojas-Canales, Michaela Waibel, Aurelien Forget, Daniella Penko, Jodie Nitschke, Fran J Harding, Bahman Delalat, Anton Blencowe, Thomas Loudovaris, Shane T Grey, Helen E Thomas, Thomas W H Kay, Chris J Drogemuller, Nicolas H Voelcker, and Patrick T Coates | |
dc.identifier.citation | Endocrine Connections, 2018; 7(3):490-503 | |
dc.identifier.doi | 10.1530/EC-17-0349 | |
dc.identifier.issn | 2049-3614 | |
dc.identifier.issn | 2049-3614 | |
dc.identifier.orcid | Grey, S. [0000-0003-2160-1625] | |
dc.identifier.orcid | Drogemuller, C. [0000-0001-9770-4845] | |
dc.identifier.uri | http://hdl.handle.net/2440/118548 | |
dc.language.iso | en | |
dc.publisher | BioScientifica | |
dc.rights | © 2018 The authors 2018. Attribution 4.0 International (CC BY 4.0) | |
dc.source.uri | https://doi.org/10.1530/ec-17-0349 | |
dc.subject | hypoxia | |
dc.subject | islet | |
dc.subject | microwell | |
dc.subject | shipping | |
dc.subject | transplantation | |
dc.title | Oxygen-permeable microwell device maintains islet mass and integrity during shipping | |
dc.type | Journal article | |
pubs.publication-status | Published |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- hdl_118548.pdf
- Size:
- 2.2 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version